Gene: MBD6
Official Full Name: methyl-CpG binding domain protein 6provided by HGNC
Gene Summary: Enables chromatin binding activity. Located in chromocenter; fibrillar center; and nucleoplasm. Implicated in autism spectrum disorder. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30767 | MBD6 Knockout cell line (HeLa) | Human | MBD6 | 1:3~1:6 | Negative | Online Inquiry |
KO30768 | MBD6 Knockout cell line (HCT 116) | Human | MBD6 | 1:2~1:4 | Negative | Online Inquiry |
KO30769 | MBD6 Knockout cell line (HEK293) | Human | MBD6 | 1:3~1:6 | Negative | Online Inquiry |
KO30770 | MBD6 Knockout cell line (A549) | Human | MBD6 | 1:3~1:4 | Negative | Online Inquiry |
MBD6 Gene Knockout Cell Lines are genetically modified cell lines designed to study the specific role of the MBD6 gene, a methyl-binding domain protein involved in the regulation of gene expression and cellular differentiation. These knockout cell lines are engineered using precise CRISPR/Cas9 technology, which allows for the targeted disruption of the MBD6 gene, enabling researchers to examine the consequences of its absence on various cellular processes.
The key function of the MBD6 gene revolves around its role in epigenetic regulation, particularly in the binding to methylated DNA and influencing chromatin structure. By utilizing MBD6 Gene Knockout Cell Lines, scientists can elucidate the mechanisms by which MBD6 modulates gene expression, potentially uncovering its impact on developmental biology, cancer progression, and various metabolic disorders. The ability to analyze the loss of MBD6 function provides insights into its physiological roles and could aid in identifying novel therapeutic targets.
The scientific significance of MBD6 Gene Knockout Cell Lines extends beyond basic research; they offer valuable applications in clinical settings, particularly in the realm of precision medicine. By studying these knockout lines, researchers can gain a deeper understanding of how MBD6-associated pathways may contribute to tumorigenesis and other diseases, ultimately informing drug development strategies.
What sets our MBD6 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability, stemming from our rigorous validation processes. Furthermore, these cell lines are readily available and come with comprehensive user guides, making them accessible for various research applications.
For researchers and clinicians seeking to investigate gene function and potential therapeutic pathways, MBD6 Gene Knockout Cell Lines represent an invaluable resource that enhances experimental capabilities and contributes to advancements in translational research. Our commitment to high-quality biological products, backed by extensive expertise in genetic engineering and gene function studies, ensures that our offerings meet the rigorous demands of modern scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.